Header

UZH-Logo

Maintenance Infos

Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease


Windisch, Paul; Guckenberger, Matthias (2019). Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease. Journal of Thoracic Disease, 11(S15):S1869-S1873.

Statistics

Citations

Altmetrics

Downloads

9 downloads since deposited on 04 Feb 2020
9 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Radiation Oncology
Dewey Decimal Classification:610 Medicine & health
Uncontrolled Keywords:Pulmonary and Respiratory Medicine
Language:English
Date:1 September 2019
Deposited On:04 Feb 2020 16:04
Last Modified:04 Feb 2020 16:04
Publisher:AME Publishing Company
ISSN:2072-1439
OA Status:Green
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.21037/jtd.2019.08.123

Download

Green Open Access

Download PDF  'Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease'.
Preview
Content: Published Version
Language: English
Filetype: PDF
Size: 165kB
View at publisher